Login / Signup

Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST).

Peter C TaylorRobin ChristensenShahrzad MoosaviPamela SelemaRuffy GuilatcoHeather FowlerMarkus MuellerKatherine F LiauBoulos Haraoui
Published in: Rheumatology advances in practice (2021)
ClinicalTrials.gov: NCT02605642.
Keyphrases
  • image quality
  • dual energy
  • computed tomography
  • contrast enhanced
  • positron emission tomography
  • adverse drug
  • magnetic resonance imaging
  • emergency department